Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd's Board of Directors, at a meeting held on April 15, 2025, approved the appointment of Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as the internal auditor of the company for the financial year 2024-2025. The meeting ran from 3:00 PM to 3:30 PM. The disclosure was made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements. The rest of the filing contains a profile brochure of the appointed audit firm.
This is a routine corporate governance update with no direct impact on financials or stock price. Shareholders may note the appointment of a new internal auditor for FY2024-25, which is a standard compliance requirement.